ArticleFrontiers in nutrition2026
Dual dimensions of sensitization: age-stratified and disease-associated sIgE profiles in pediatric eczema and urticaria.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize sensitization patterns of allergen-specific immunoglobulin E (sIgE) in children with eczema and urticaria, compare differences by disease type and age group, and provide insights for prevention and treatment strategies. Methods: A single-center, retrospective cross-sectional study was performed using serum samples from 4,925 children diagnosed with eczema or urticaria at Henan Children's Hospital between January 2022 and December 2023. Levels of sIgE to inhaled and food allergens were measured using fluorescence immunoassay. Group differences in sensitization rates were compared using chi-square tests, and Spearman correlation analysis was applied to assess relationships between sIgE levels and clinical parameters. Results: The overall positive rate of sIgE was 58.05%, with the positive rate for food allergens (52.93%) significantly higher than that for inhalant allergens (14.05%) ( Conclusion: This study identified distinct age-dependent sIgE sensitization profiles, while disease-associated differences were attenuated after accounting for age and sex. These findings highlight age as a primary dimension for sensitization risk stratification and underscore the clinical value of integrating sIgE monitoring with other biomarkers, such as eosinophils and hemoglobin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.